News

September 22, 2014 — A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of...

U.S. CoreValve High Risk trial TCT 2014

According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (SAVR) in high risk patients with...

PARTNER I Trial TCT 2014 TAVR Heart Valve Repair

New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and...

St. Jude Medical Portico TAVR System Minneapolis Heart Institute Implant Trial

The Minneapolis Heart Institute Foundation (MHIF) announced its first implant of the Portico Re-sheathable Transcatheter Aortic Valve System, developed by St. Jude Medical. 

September 15, 2014 — A new gene-directed drug being tested through a research study called GENETIC-AF may improve care, quality of life and survival in patients with heart failure and atrial...

Claret Medical Cerebral Protection Series B Financing Sentinel CPS System

Claret Medical Inc. announced that it has entered into an agreement for up to $18 million in a Series B financing. The Series B round was led by Santé Ventures, a prominent healthcare-focused...

Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

Claret Medical Sentinel Cerebral Protection System Celebral Protection

Claret Medical Inc. vascular and cardiac surgery procedures, announced that it has entered into an agreement for up to $18 million in a Series B financing.

September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent...

stem cells, cytori, stem cell therapy

The Cardiovascular Cell Therapy Research Network (CCTRN), has selected Cytori Therapeutics, Inc. to supply adipose-derived regenerative cells (ADRCs) for a clinical trial aimed at...

heart valve, heart surgery

For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just...

August 29, 2014 — Direct Flow Medical announced it received CE mark for a 23 mm valve as part of its Direct Flow Medical transcatheter aortic valve system, expanding the patient population...

August 28, 2014 — The University of Michigan Frankel Cardiovascular Center is the first heart center in the nation to perform percutaneous implantation of the Edwards Sapien valve to...

August 27, 2014 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application for transcatheter...

Cedars-Sinai Heart Institute Clinic Heart Vascular Disease Stem Cell Studies

Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.

August 15, 2014 — Mardil Medical announced earlier this year the first-in-human implants using the VenTouch ventricular reshaping device performed by a surgical team at the Institut...

August 12, 2014 — The Centers for Medicare and Medicaid (CMS) took action to improve access to Abbott’s MitraClip system after issuing its fiscal year 2015 ruling on the inpatient prospective...

August 5, 2014 — A survey, published online in the European Journal of Cardio-Thoracic Surgery, of 13,860 patients who had undergone interventions for aortic valve disease in Germany...

Sorin Group Solo Smart Heart Valve Repair

Sorin Group received U.S. Food and Drug Administration (FDA) approval for the Solo Smart Aortic Pericardial Heart Valve.

Occlutech announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice in London that invalidates AGA/St Jude's patent —EP0957773B1 in the United...